VMA21 deficiency causes an autophagic myopathy by compromising V-ATPase activity and lysosomal acidification

• Published in: Cell Vol. 137; no. 2; pp. 235 - 246
• Main Authors: Ramachandran, Nivetha, Munteanu, Iulia, Wang, Peixiang, Aubourg, Pauline, Rilstone, Jennifer J, Israelian, Nyrie, Naranian, Taline, Paroutis, Paul, Guo, Ray, Ren, Zhi-Ping, Nishino, Ichizo, Chabrol, Brigitte, Pellissier, Jean-Francois, Minetti, Carlo, Udd, Bjarne, Fardeau, Michel, Tailor, Chetankumar S, Mahuran, Don J, Kissel, John T, Kalimo, Hannu, Levy, Nicolas, Manolson, Morris F, Ackerley, Cameron A, Minassian, Berge A
• Format: Journal Article
• Language: English
• Published: United States 17.04.2009
• Subjects: Autophagy; Genes, X-Linked; Humans; Lysosomes - metabolism; Membrane Proteins - metabolism; Muscular Diseases - genetics; RNA, Messenger - metabolism; Saccharomyces cerevisiae Proteins - metabolism; Vacuolar Proton-Translocating ATPases - genetics; Vacuolar Proton-Translocating ATPases - metabolism
• ISSN: 1097-4172
• DOI: 10.1016/j.cell.2009.01.054

X-linked myopathy with excessive autophagy (XMEA) is a childhood-onset disease characterized by progressive vacuolation and atrophy of skeletal muscle. We show that XMEA is caused by hypomorphic alleles of the VMA21 gene, that VMA21 is the diverged human ortholog of the yeast Vma21p protein, and that like Vma21p it is an essential assembly chaperone of the V-ATPase, the principal mammalian proton pump complex. Decreased VMA21 raises lysosomal pH, which reduces lysosomal degradative ability and blocks autophagy. This reduces cellular free amino acids, which upregulates the mTOR pathway and mTOR-dependent macroautophagy, resulting in proliferation of large and ineffective autolysosomes that engulf sections of cytoplasm, merge together, and vacuolate the cell. Our results uncover macroautophagic overcompensation leading to cell vacuolation and tissue atrophy as a mechanism of disease.